Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

BACKGROUND: Neuroendocrine tumors (NETs) are rare neoplasms, with an estimated annual incidence of ~ 6.9/100,000. NETs arise throughout the body from cells of the diffuse endocrine system. More than half originate from endocrine cells of the gastrointestinal tract and the pancreas, thus being referr...

Descripción completa

Detalles Bibliográficos
Autores principales: Uri, Inbal, Grozinsky-Glasberg, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042326/
https://www.ncbi.nlm.nih.gov/pubmed/30009041
http://dx.doi.org/10.1186/s40842-018-0066-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042326/
https://www.ncbi.nlm.nih.gov/pubmed/30009041
http://dx.doi.org/10.1186/s40842-018-0066-3

Ejemplares similares